Skip to main content
Top
Published in: Obesity Surgery 11/2015

Open Access 01-11-2015 | Original Contributions

Contraceptive Use Before and After Gastric Bypass: a Questionnaire Study

Authors: Charlotte Ginstman, Jessica Frisk, Johan Ottosson, Jan Brynhildsen

Published in: Obesity Surgery | Issue 11/2015

Login to get access

Abstract

Background

At present, women are recommended to avoid pregnancy 12–18 months after bariatric surgery. Our aim in this study was to describe patterns of contraceptive use before and after gastric bypass in Sweden, and to describe the contraceptive counseling given preoperatively to women undergoing gastric bypass.

Methods

In October 2012, a questionnaire was sent to 1000 Swedish women who all had undergone gastric bypass during 2010. The women had been included in the Scandinavian Obesity Surgery Register at time of surgery. The main outcome measures were patterns of use of contraception before and after bariatric surgery.

Results

The response rate was 57 %. The most commonly used contraceptive methods were intrauterine devices, 29 % preoperatively and 26 % postoperatively even though there was a postoperative switch from the copper intrauterine device to the levonorgestrel intrauterine system. Thirty percent did not use any contraceptive during the first 12 months after surgery. Sixty percent of the responders were aware of the recommendations to avoid pregnancy after surgery.

Conclusions

Many women who undergo bariatric surgery are not using any contraceptive method despite the recommendation that they should avoid pregnancy for at least 12 months. There is a great need to improve contraceptive counseling for this growing group of women.
Literature
2.
go back to reference Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142(7):547–59.CrossRefPubMed Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142(7):547–59.CrossRefPubMed
3.
go back to reference SOReg. Annual Report SOReg 2013. Scandinavian Obesity Surgery Register [In Swedish]. 2014 SOReg. Annual Report SOReg 2013. Scandinavian Obesity Surgery Register [In Swedish]. 2014
4.
5.
go back to reference Roos N, Neovius M, Cnattingius S, Trolle Lagerros Y, Saaf M, Granath F, et al. Perinatal outcomes after bariatric surgery: nationwide population based matched cohort study. BMJ. 2013;347:f6460.PubMedCentralCrossRefPubMed Roos N, Neovius M, Cnattingius S, Trolle Lagerros Y, Saaf M, Granath F, et al. Perinatal outcomes after bariatric surgery: nationwide population based matched cohort study. BMJ. 2013;347:f6460.PubMedCentralCrossRefPubMed
6.
go back to reference Granstrom L, Granstrom L, Backman L. Fetal growth retardation after gastric banding. Acta Obstet Gynecol Scand. 1990;69(6):533–6.CrossRefPubMed Granstrom L, Granstrom L, Backman L. Fetal growth retardation after gastric banding. Acta Obstet Gynecol Scand. 1990;69(6):533–6.CrossRefPubMed
7.
go back to reference American College of O, Gynecologists. ACOG practice bulletin no. 105: bariatric surgery and pregnancy. Obstet Gynecol. 2009;113(6):1405–13.CrossRef American College of O, Gynecologists. ACOG practice bulletin no. 105: bariatric surgery and pregnancy. Obstet Gynecol. 2009;113(6):1405–13.CrossRef
8.
go back to reference Gerrits EG, Ceulemans R, van Hee R, Hendrickx L, Totte E. Contraceptive treatment after biliopancreatic diversion needs consensus. Obes Surg. 2003;13(3):378–82.CrossRefPubMed Gerrits EG, Ceulemans R, van Hee R, Hendrickx L, Totte E. Contraceptive treatment after biliopancreatic diversion needs consensus. Obes Surg. 2003;13(3):378–82.CrossRefPubMed
9.
go back to reference Beard JH, Bell RL, Duffy AJ. Reproductive considerations and pregnancy after bariatric surgery: current evidence and recommendations. Obes Surg. 2008;18(8):1023–7.CrossRefPubMed Beard JH, Bell RL, Duffy AJ. Reproductive considerations and pregnancy after bariatric surgery: current evidence and recommendations. Obes Surg. 2008;18(8):1023–7.CrossRefPubMed
10.
go back to reference Berlac JF, Skovlund CW, Lidegaard O. Obstetrical and neonatal outcomes in women following gastric bypass: a Danish national cohort study. Acta Obstet Gynecol Scand. 2014;93(5):447–53.CrossRefPubMed Berlac JF, Skovlund CW, Lidegaard O. Obstetrical and neonatal outcomes in women following gastric bypass: a Danish national cohort study. Acta Obstet Gynecol Scand. 2014;93(5):447–53.CrossRefPubMed
12.
go back to reference Tandra S, Chalasani N, Jones DR, Mattar S, Hall SD, Vuppalanchi R. Pharmacokinetic and pharmacodynamic alterations in the Roux-en-Y gastric bypass recipients. Ann Surg. 2013;258(2):262–9.CrossRefPubMed Tandra S, Chalasani N, Jones DR, Mattar S, Hall SD, Vuppalanchi R. Pharmacokinetic and pharmacodynamic alterations in the Roux-en-Y gastric bypass recipients. Ann Surg. 2013;258(2):262–9.CrossRefPubMed
13.
go back to reference Victor A, Odlind V, Kral JG. Oral contraceptive absorption and sex hormone binding globulins in obese women: effects of jejunoileal bypass. Gastroenterol Clin N Am. 1987;16(3):483–91. Victor A, Odlind V, Kral JG. Oral contraceptive absorption and sex hormone binding globulins in obese women: effects of jejunoileal bypass. Gastroenterol Clin N Am. 1987;16(3):483–91.
14.
go back to reference Holt VL, Scholes D, Wicklund KG, Cushing-Haugen KL, Daling JR. Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol. 2005;105(1):46–52.CrossRefPubMed Holt VL, Scholes D, Wicklund KG, Cushing-Haugen KL, Daling JR. Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol. 2005;105(1):46–52.CrossRefPubMed
15.
go back to reference Brunner LR, Hogue CJ. The role of body weight in oral contraceptive failure: results from the 1995 national survey of family growth. Ann Epidemiol. 2005;15(7):492–9.CrossRefPubMed Brunner LR, Hogue CJ. The role of body weight in oral contraceptive failure: results from the 1995 national survey of family growth. Ann Epidemiol. 2005;15(7):492–9.CrossRefPubMed
16.
go back to reference Westhoff CL, Torgal AH, Mayeda ER, Stanczyk FZ, Lerner JP, Benn EK, et al. Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial. Obstet Gynecol. 2010;116(2 Pt 1):275–83.CrossRefPubMed Westhoff CL, Torgal AH, Mayeda ER, Stanczyk FZ, Lerner JP, Benn EK, et al. Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial. Obstet Gynecol. 2010;116(2 Pt 1):275–83.CrossRefPubMed
17.
go back to reference Mody SK, Hacker MR, Dodge LE, Thornton K, Schneider B, Haider S. Contraceptive counseling for women who undergo bariatric surgery. J Women’s Health. 2011;20(12):1785–8.CrossRef Mody SK, Hacker MR, Dodge LE, Thornton K, Schneider B, Haider S. Contraceptive counseling for women who undergo bariatric surgery. J Women’s Health. 2011;20(12):1785–8.CrossRef
18.
go back to reference G.B. W. Cognitive interviewing: a “how to” guide. 1999 Meeting of the American Statistical Association1999 G.B. W. Cognitive interviewing: a “how to” guide. 1999 Meeting of the American Statistical Association1999
19.
go back to reference Läkemedelsverket. Antikonception-behandlingsrekommendation. Inf från läkemedelsverket. 2014;25(2):14–28. In Swedish. 2014. Läkemedelsverket. Antikonception-behandlingsrekommendation. Inf från läkemedelsverket. 2014;25(2):14–28. In Swedish. 2014.
20.
go back to reference Pomp ER, le Cessie S, Rosendaal FR, Doggen CJ. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol. 2007;139(2):289–96.CrossRefPubMed Pomp ER, le Cessie S, Rosendaal FR, Doggen CJ. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol. 2007;139(2):289–96.CrossRefPubMed
21.
go back to reference Abdollahi M, Cushman M, Rosendaal FR. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost. 2003;89(3):493–8.PubMed Abdollahi M, Cushman M, Rosendaal FR. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost. 2003;89(3):493–8.PubMed
22.
go back to reference Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA : J Am Med Assoc. 1997;277(8):642–5.CrossRef Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA : J Am Med Assoc. 1997;277(8):642–5.CrossRef
23.
go back to reference ACOG Committee on Practice Bulletins-Gynecology. ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2006;107(6):1453–72.CrossRef ACOG Committee on Practice Bulletins-Gynecology. ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2006;107(6):1453–72.CrossRef
24.
go back to reference Norgaard LN, Gjerris AC, Kirkegaard I, Berlac JF, Tabor A. Danish Fetal Medicine Research G. Fetal growth in pregnancies conceived after gastric bypass surgery in relation to surgery-to-conception interval: a Danish national cohort study. PLoS One. 2014;9(3):e90317.PubMedCentralCrossRefPubMed Norgaard LN, Gjerris AC, Kirkegaard I, Berlac JF, Tabor A. Danish Fetal Medicine Research G. Fetal growth in pregnancies conceived after gastric bypass surgery in relation to surgery-to-conception interval: a Danish national cohort study. PLoS One. 2014;9(3):e90317.PubMedCentralCrossRefPubMed
25.
go back to reference Kim MJ, Marchand P, Henegar C, Antignac JP, Alili R, Poitou C, et al. Fate and complex pathogenic effects of dioxins and polychlorinated biphenyls in obese subjects before and after drastic weight loss. Environ Health Perspect. 2011;119(3):377–83.PubMedCentralCrossRefPubMed Kim MJ, Marchand P, Henegar C, Antignac JP, Alili R, Poitou C, et al. Fate and complex pathogenic effects of dioxins and polychlorinated biphenyls in obese subjects before and after drastic weight loss. Environ Health Perspect. 2011;119(3):377–83.PubMedCentralCrossRefPubMed
Metadata
Title
Contraceptive Use Before and After Gastric Bypass: a Questionnaire Study
Authors
Charlotte Ginstman
Jessica Frisk
Johan Ottosson
Jan Brynhildsen
Publication date
01-11-2015
Publisher
Springer US
Published in
Obesity Surgery / Issue 11/2015
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-015-1641-7

Other articles of this Issue 11/2015

Obesity Surgery 11/2015 Go to the issue